News | August 08, 2022
Valiant Organics to start production of OAP and Pharma Intermediates
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
The plant is scheduled to come on stream in September 2024
India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
The company expects meaningful revenue contribution from this long-term agreement
The CDMO upgrade represents a transformational step for Remedium Lifecare
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Subscribe To Our Newsletter & Stay Updated
